Search research articles
Contact Us
Filters
Showing results (311-320 of 418) with videos related to
Page
of 42
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
October 19, 2013
Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group
Nicolas Isambert, Isabelle Ray-Coquard, Antoine Italiano, et al.
Cancer Research Communications
|
September 3, 2025
IPH5201, an anti-CD39 monoclonal antibody, as monotherapy or in combination with durvalumab in advanced solid tumors
John Powderly, Martina Imbimbo, Antoine Italiano, et al.
The Lancet. Oncology
|
April 14, 2018
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Antoine Italiano, Jean-Charles Soria, Maud Toulmonde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial
Isabelle L Ray-Coquard, Julien Domont, Emmanuelle Tresch-Bruneel, et al.
Eclinicalmedicine
|
May 31, 2019
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
Alessandro Gronchi, Nadia Hindi, Josefina Cruz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 25, 2021
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study
Florence Duffaud, Antoine Italiano, Emannuelle Bompas, et al.
Cancer Treatment and Research Communications
|
July 30, 2021
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer
Emiliano Calvo, Alexander Spira, María de Miguel, et al.
The Lancet. Oncology
|
February 21, 2020
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial
Antoine Italiano, Olivier Mir, Simone Mathoulin-Pelissier, et al.
Cell Reports. Medicine
|
November 26, 2024
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
Jean-Philippe Guégan, Florent Peyraud, Bérengère Dadone-Montaudie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 4, 2025
Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline - update 2024
Philippe Saiag, Celeste Lebbe, Lieve Brochez, et al.
Page
of 42
Search research articles
Search
Showing results (311-320 of 418) with videos related to
Sort By:
Page
of 42
European Journal of Cancer (Oxford, England : 1990)
|
October 19, 2013
Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group
Nicolas Isambert, Isabelle Ray-Coquard, Antoine Italiano, et al.
Cancer Research Communications
|
September 3, 2025
IPH5201, an anti-CD39 monoclonal antibody, as monotherapy or in combination with durvalumab in advanced solid tumors
John Powderly, Martina Imbimbo, Antoine Italiano, et al.
The Lancet. Oncology
|
April 14, 2018
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Antoine Italiano, Jean-Charles Soria, Maud Toulmonde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial
Isabelle L Ray-Coquard, Julien Domont, Emmanuelle Tresch-Bruneel, et al.
Eclinicalmedicine
|
May 31, 2019
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
Alessandro Gronchi, Nadia Hindi, Josefina Cruz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 25, 2021
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study
Florence Duffaud, Antoine Italiano, Emannuelle Bompas, et al.
Cancer Treatment and Research Communications
|
July 30, 2021
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer
Emiliano Calvo, Alexander Spira, María de Miguel, et al.
The Lancet. Oncology
|
February 21, 2020
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial
Antoine Italiano, Olivier Mir, Simone Mathoulin-Pelissier, et al.
Cell Reports. Medicine
|
November 26, 2024
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
Jean-Philippe Guégan, Florent Peyraud, Bérengère Dadone-Montaudie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 4, 2025
Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline - update 2024
Philippe Saiag, Celeste Lebbe, Lieve Brochez, et al.
Page
of 42